The main effectors of Th1 cells are interleukin (IL)-2 and interferon (IFN)-γ, which can indirectly or directly promote and maintain the proliferation and activation of T cells, induce and enhance the anti-tumor activity of NK cells, and inhibit the division and proliferation of tumor cells (Thakur et al., 2012). Here, IL2 is linked to neoplasm.